Similar articles

• Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.

  Desgranges C, de-The G. Desgranges C, et al. IARC Sci Publ (1971). 1978;(20):459-69. IARC Sci Publ (1971). 1978. PMID: 215528 No abstract available.
• Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients.

  Desgranges C, De-Thé G, Ho JH, Ellouz R. Desgranges C, et al. Int J Cancer. 1977 May 15;19(5):627-33. doi: 10.1002/ijc.2910190506. Int J Cancer. 1977. PMID: 193801
• The EB virus in relation to infectious mononucleosis.

  Sutton RN. Sutton RN. J Clin Pathol Suppl (R Coll Pathol). 1972;6:58-64. J Clin Pathol Suppl (R Coll Pathol). 1972. PMID: 4376156 Free PMC article. Review. No abstract available.
• Serum IgA antibodies of Epstein-Barr virus (EBV)-related antigens. A new feature of nasopharyngeal carcinoma.

  Henle G, Henle W. Henle G, et al. Bibl Haematol. 1975 Oct;(43):322-5. doi: 10.1159/000399157. Bibl Haematol. 1975. PMID: 183692 No abstract available.
• [Immunological study of nasopharyngeal carcinoma].

  Tachibana T. Tachibana T. Nihon Ishikai Zasshi. 1971 Jun 1;65(11):1387-98. Nihon Ishikai Zasshi. 1971. PMID: 4327018 Review. Japanese. No abstract available.